Cargando…
Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report
Hypokalemia can cause abnormalities in multiple systems. Long term use of antipsychotic medications can lead to electrolyte imbalance, including hypokalemia. We report a 49-year-old female patient with schizophrenia who developed hypokalemia after oral quetiapine and risperidone treatments. Her bloo...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410402/ https://www.ncbi.nlm.nih.gov/pubmed/30858673 http://dx.doi.org/10.11919/j.issn.1002-0829.217168 |
Ejemplares similares
-
Switching to quetiapine for risperidone-induced amenorrhea: Report of two cases
por: Pardal, P. K., et al.
Publicado: (2010) -
Immune-globulin/quetiapine/risperidone: Lack of efficacy: case report
Publicado: (2022) -
A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
por: Alamri, Sultan H
Publicado: (2018) -
Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018) -
PM413. Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone
por: Newcomer, John W., et al.
Publicado: (2016)